Paracetamol disposition in renal allograft recipients

被引:3
|
作者
Martin, U [1 ]
Temple, RM
Venkat-Raman, G
Prescott, LF
机构
[1] Queen Elizabeth Hosp, Dept Med, Clin Invest Unit, Birmingham B15 2TH, W Midlands, England
[2] Birmingham Heartlands Hosp, Dept Renal Med, Birmingham B9 5ST, W Midlands, England
[3] St Marys Hosp, Wessex Renal & Transplant Unit, Porstmouth, England
[4] Univ Edinburgh, Edinburgh, Midlothian, Scotland
关键词
paracetamol; renal allograft;
D O I
10.1007/s00228-001-0409-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To evaluate the disposition of paracetamol in renal allograft recipients. Method: Eight fasting renal allograft recipients were given 1 g soluble paracetamol orally. Results: Paracetamol was absorbed rapidly, and the mean plasma half-life from 2 h to 8 h was 2.6 +/- 0.5 h. After that, disappearance of paracetamol from the plasma was slower. Both the glucuronide and sulphate conjugates of paracetamol had slow elimination half-lives of 15.1 +/- 8.8 h and 26.2 +/- 14.6 h, and there were residual amounts of both conjugates in the plasma at 24 h. The renal clearances of both conjugates were low (21 +/- 14.2 ml/min and 32.4 +/- 31.4 ml/min) and there was a significant negative correlation between total amount of paracetamol recovered in the urine in 24 h and serum creatinine (r=-0.89, P<0.01). Conclusion: Paracetamol disposition is abnormal in renal allograft recipients and seems to relate to abnormal renal function in these patients.
引用
收藏
页码:853 / 856
页数:4
相关论文
共 50 条
  • [31] Disposition kinetics and dosage regimen of levofloxacin on concomitant administration with paracetamol in crossbred calves
    Dumka, Vinod K.
    JOURNAL OF VETERINARY SCIENCE, 2007, 8 (04) : 357 - 360
  • [32] Influence of the Time of Intravenous Administration of Paracetamol on its Pharmacokinetics and Ocular Disposition in Rabbits
    Agnieszka Karbownik
    Agnieszka Bienert
    Włodzimierz Płotek
    Tomasz Grabowski
    Magdalena Cerbin-Koczorowska
    Anna Wolc
    Edmund Grześkowiak
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 489 - 498
  • [33] Plasma disposition of paracetamol on co-administration with levofloxacin in cross bred calves
    Dumka, V. K.
    Singh, Harpreet
    Srivastava, A. K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES INDIA SECTION B-BIOLOGICAL SCIENCES, 2009, 79 : 129 - 134
  • [34] Mucormycosis (zygomycosis) of renal allograft
    Gupta, Krishan L.
    Joshi, Kusum
    Kohli, Harbir S.
    Jha, Vivekanand
    Sakhuja, Vinay
    CLINICAL KIDNEY JOURNAL, 2012, 5 (06) : 502 - 507
  • [35] Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parameters
    Fehr, T
    Riehle, HM
    Nigg, L
    Grüter, E
    Ammann, P
    Renner, EL
    Ambühl, PM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (01) : 193 - 201
  • [36] LONG-TERM GRAFT-SURVIVAL AND RENAL-FUNCTION IN CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS - LACK OF EVIDENCE OF NEPHROTOXICITY
    SNIDER, J
    FRANCIS, DMA
    KINCAIDSMITH, P
    WALKER, RG
    CLINICAL TRANSPLANTATION, 1993, 7 (01) : 25 - 27
  • [37] Urinary transforming growth factor-β1 excretion in renal allograft recipients during the early post-transplantation period
    Goumenos, DS
    Tsakas, S
    Karavias, D
    Savidaki, I
    Karatzas, T
    Vlachojannis, JG
    RENAL FAILURE, 2003, 25 (04) : 561 - 568
  • [38] Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients
    Sener, A
    House, AA
    Jevnikar, AM
    Boudville, N
    McAlister, VC
    Muirhead, N
    Rehman, F
    Luke, PPW
    TRANSPLANTATION, 2006, 81 (01) : 117 - 120
  • [39] CC-chemokine RANTES is increased in serum and urine in the early post-transplantation period of human renal allograft recipients
    Baer, PC
    Koziolek, M
    Fierlbeck, W
    Geiger, H
    KIDNEY & BLOOD PRESSURE RESEARCH, 2005, 28 (01) : 48 - 54
  • [40] Decreased humoral antibody episodes of acute renal allograft rejection in recipients expressing the HLA-DQβ1*0202 allele
    Mannam, Venkat K. R.
    Santos, Mark
    Lewis, Robert E.
    Cruse, Julius M.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2012, 93 (02) : 190 - 192